Raquel De Paz Arias

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

Lionel Adès, Larisa Girshova, Vadim Doronin et al. · Blood Advances · 2022 · 121 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg

Raquel De Paz Arias, John K. Jain, Cosima Brucker et al. · Contraception · 2006 · 59 citations

Pharmacy, Pharmacology, Pharmacotherapy +5

Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts

William H. Hindle, Raquel De Paz Arias, Barbara D. Florentine et al. · American Journal of Obstetrics and Gynecology · 2000 · 26 citations

Medicine, Pathology, Cytopathology +13

No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19

Paula Lázaro del Campo, Raquel De Paz Arias, Andrés Ramírez López et al. · Transfusion and Apheresis Science · 2020 · 24 citations · Full text

Medicine, Hematology, Infectious Diseases +15

Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multicenter Clinical Trial

Félix López Cadenas, Eva Lumbreras, Teresa González et al. · Blood · 2022 · 18 citations

Medicine, Hematology, Pharmacology +4